Associated Papers
Activating NOTCH1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Responsiveness to Notch1 Inhibitors.
Ferrarotto R et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 2017
Select a paper to view details